万邦医药：12月25日召开董事会会议

Group 1 - The core point of the article is that Wanbang Medical (SZ 301520) announced the convening of its third board meeting on December 25, 2025, to discuss the proposal for the 2026 first extraordinary shareholders' meeting [1] - For the year 2024, Wanbang Medical's revenue composition is entirely from the CRO industry, accounting for 100.0% [1] - As of the report date, Wanbang Medical has a market capitalization of 2.7 billion yuan [1]